Make Yourself Count - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Make Yourself Count
This year, the employment survey will acknowledge the industry's best employees.


Pharmaceutical Technology
Volume 9, Issue 32, pp. 16


Maribel Rios
Pharmaceutical Technology has been the authoritative source of the industry for more than 30 years. One of our unique resources is the annual employment survey, which has been part of this publication for the past 20 years. The article, appearing in the December issue, is more than a salary update; it provides a look into the industry workplace from the perspective of those who know it best. Readers have let us know that they turn to the survey as one of their resources when making hiring decisions or future career plans.

Globalization is leading to big changes in the industry, but one of the most universal topics of interest to professionals worldwide is the current work environment. About 10 years ago, to make the results of the employment survey more comprehensive, we gave the survey an international perspective. This year, we would like to expand on this goal and encourage even greater participation from our readers outside the United States.

We've also added a new segment to this year's survey. Recognizing that high levels of job satisfaction come from good employers, the questionnaire invites participants to nominate their company as one of the "Best Companies to Work for" in the industry. Past survey participants have voiced their opinions about what they enjoy the best about their jobs, and many of these opinions have centered around the job environment at their particular company. This year, we hope to recognize these companies and perhaps inspire new and future employers.

We invite you to click here anytime until Sept. 30 to make yourself count and participate in this important survey. And perhaps you may want to nominate your company as one of the "Best Companies to Work for" in the pharmaceutical industry.

Maribel Rios is a senior editor at Pharmaceutical Technology.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here